HEREDITARY SPASTIC PARAPLEGIA
Clinical trials for HEREDITARY SPASTIC PARAPLEGIA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY SPASTIC PARAPLEGIA trials appear
Sign up with your email to follow new studies for HEREDITARY SPASTIC PARAPLEGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One Patient's hope: can an old TB drug help a rare paralysis condition?
Disease control CompletedThis study tested the drug D-cycloserine in a single patient with a rare genetic form of hereditary spastic paraplegia. The goal was to see if the drug is safe and can slow the disease by lowering certain fats (sphingolipids) in the body. The patient also took pyridoxine to help …
Matched conditions: HEREDITARY SPASTIC PARAPLEGIA
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New muscle relaxant drug MTR-601 tested in humans for first time
Symptom relief CompletedThis early-stage trial tested a new oral drug called MTR-601 in 89 healthy adults to see if it is safe and how the body processes it. The drug aims to reduce muscle stiffness and spasms, which could help people with conditions like cerebral palsy, multiple sclerosis, or stroke. S…
Matched conditions: HEREDITARY SPASTIC PARAPLEGIA
Phase: PHASE1 • Sponsor: Motric Bio • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC